Andere talen RaQualia Pharma Inc.

Aandelen

4579

JP3967150008

Vertraagde tijd Japan Exchange Andere beurzen 02:03:10 20-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
589 ^JPY	-0,67%		+1,73%	-14,39%

26/03	RaQualia Pharma Inc. (TSE:4579) heeft de overname afgerond van FIMECS, Inc. van Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership, beheerd door Nissay Capital Co., Ltd., ANRI No. 4 Fund, beheerd door ANRI en anderen.	CI
14/02	RaQualia Pharma Inc. Geeft geconsolideerde winstverwachting voor het jaar dat eindigt op 31 december 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	26/03
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	14/02
RaQualia Pharma Inc. agreed to acquire FIMECS, Inc. from Nissay Capital No. 11 Investment Limited Partnership and Nissay Capital Co., Ltd. for ¥4.5 billion.	14/02
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	10-08-23
Constipation Pipeline, Clinical Trials, and Key Companies\|Companies-Anji Pharma, Yuhan, Theravance Biopharma	12-06-23
RaQualia Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	15-05-23
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	14-02-23
RaQualia Pharma Inc. announced that it has received ¥805.6125 million in funding from CVI Investments, Inc.	05-01-23
RaQualia Pharma Inc. announced that it expects to receive Ã‘805.6125 million in funding from CVI Investments, Inc.	20-12-22
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for Year Ending December 31, 2022	11-11-22
RaQualia Pharma : Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (JGAAP)	15-08-22
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022	15-08-22
RaQualia Pharma : (Delayed)Summary of Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 (JGAAP)	15-02-22
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022	15-02-22
RaQualia Pharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	12-11-21
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2021	12-08-21
RaQualia Pharma Inc. Announces Consolidated Financial Results for the Six Months Ended June 30, 2021	12-08-21
RaQualia Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2021	14-05-21
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	14-05-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen RaQualia Pharma Inc.

Aandelen

4579

JP3967150008

Andere talen

Filters